Skip to main content

Advertisement

Table 5 Characteristics of people without monitored renal function compared to those with monitored renal function

From: Association of chronic kidney disease (CKD) and failure to monitor renal function with adverse outcomes in people with diabetes: a primary care cohort study

  Renal function not monitored (N = 4460) n (%) Renal function monitored (N = 31042) n (%) P =
Age: mean (±SD) 59.1 years (±16.5) 64.2 years (±13.9) <0.001
Gender: male 2,434 (54.6%) 16,764 (53.9%) 0.432
Ethnicity N = 2,227 N = 23,986  
White 1,232 (55.3) 13,990 (58.3)  
Mixed 37 (1.7) 369 (1.5)  
Asian 480 (21.6) 5,735 (23.9)  
Black 210 (9.4) 1,973 (8.2)  
Other 268 (12.0) 1,919 (8.0) <0.001
Smoking Status N = 2765 N = 25263  
Never smoked 1,562 (56.5) 14,787 (58.5)  
Current Smoker 741 (26.8) 5,879 (18.2)  
Ex-smoker 462 (16.7) 4,597 (18.2) <0.001
Alcohol Consumption N = 1,662 N = 21568  
No alcohol 736 (44.3) 10,514 (48.7)  
Light alcohol 707 (42.5) 9,417 (43.7)  
Excess alcohol 194 (11.7) 1,531 (7.1)  
Previous excess alcohol 25 (1.5) 106 (0.5) <0.001
Investigations    
HbA1c: not monitored 1,496 (33.5) 1,939 (6.2) <0.001
HbA1c: mean (±SD) 8.16% (±2.09) 8.55 (±2.07) <0.001
Total cholesterol: not monitored 1,413 (31.7) 633 (2.0) <0.001
Total cholesterol: mean (±SD) 4.93 mmol/l (±1.15) 4.60 mmol/l (±1.08) <0.001
LDL cholesterol: not monitored 2,510 (56.3) 13,168 (42.4) <0.001
LDL cholesterol: mean (±SD) 2.70 mmol/l (±0.99) 2.51 mmol/l (±0.91) <0.001
HDL cholesterol: not monitored 1,688 (37.8) 4,162 (13.4) <0.001
HDL cholesterol: mean (±SD) 1.35 mmol/l (±0.39) 1.29 mmol/l (±0.38) <0.001
Medications    
ACE/ARBs prescribed 1,847 (41.4) 20,403 (65.7) <0.001
Lipid lowering drugs prescribed 2,134 (47.8) 24,136 (77.8) <0.001
Aspirin prescribed 801 (18.0) 9,081 (29.3) <0.001
  1. For ethnicity, smoking status, and alcohol consumption only those with recorded values are included. Abbreviations: SD, standard deviation.